MetaVia is trading at $1.34, up +6.35%, in after-hours trading, with no clear company-specific catalyst identified.
- This compares with the $1.26 regular-session close, according to the supplied price context.
- MetaVia’s latest listed company announcement was its October 13 appointment of a chief medical officer, not an October 16 update.
- Reuters reported renewed pressure on technology stocks October 16 amid AI-infrastructure financing concerns; this does not establish why MetaVia rose after hours.